Literature DB >> 17936933

Human carboxylesterases and their role in xenobiotic and endobiotic metabolism.

Matthew K Ross1, J Allen Crow.   

Abstract

Carboxylesterases (CEs) are traditionally regarded as xenobiotic metabolizing enzymes that hydrolyze esterified xenobiotics to alcohol and carboxylic acid products. However, there is a growing appreciation for the role of CEs in the processing of endobiotics, including cholesteryl esters and triacylglycerols. Human liver microsomes (HLMs) are often used in reaction phenotyping studies to discern interindividual variability in xenobiotic metabolism. The two major CE isoforms expressed in human liver are hCE1 and hCE2. These two isoforms are different gene products. We have begun studies to evaluate the CE phenotype'' of human liver samples, i.e. to determine both the levels of hCE1 and hCE2 protein and the hydrolytic activity of each. We have previously shown that there is little variation in hCE1 protein expression in HLM samples from 11 individuals [a 1.3-fold difference between the highest and lowest individuals; coefficient of variation (CV), 9%]. hCE2 protein expression in individual HLMs is only slightly more variable than hCE1 (2.3-fold difference between the highest and lowest individuals; CV, 36%). However, hCE1 protein is found in 46-fold higher amounts in HLMs than hCE2 protein (64.4 +/- 16.5 microg hCE1/mg microsomal protein compared to 1.4 +/- 0.2 microg hCE2/mg microsomal protein). The hydrolytic activity specifically attributable to hCE1 and hCE2 in individual HLMs was measured using bioresmethrin (a pyrethroid insecticide hydrolyzed specifically by hCE1, but not by hCE2) and procaine (an analgesic drug hydrolyzed by hCE2, but not by hCE1). The hydrolytic activity of individual HLMs toward bioresmethrin and procaine did not correlate with the protein content of hCE1 and hCE2. Thus, the mere abundance of CE proteins is not a good predictor of CE activity in HLMs. Identification of the factors that lead to altered CE activities in HLMs will be important to characterize since several pharmaceutical agents, environmental toxicants, and endobiotics are metabolized by these enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936933     DOI: 10.1002/jbt.20178

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  29 in total

1.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Authors:  Shuqi Xie; Abdolsamad Borazjani; M Jason Hatfield; Carol C Edwards; Philip M Potter; Matthew K Ross
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

2.  Isoform-Specific Regulation of Mouse Carboxylesterase Expression and Activity by Prototypical Transcriptional Activators.

Authors:  Angela A Baker; Grace L Guo; Lauren M Aleksunes; Jason R Richardson
Journal:  J Biochem Mol Toxicol       Date:  2015-07-15       Impact factor: 3.642

3.  Control of RhoA methylation by carboxylesterase I.

Authors:  Ian Cushman; Stephanie M Cushman; Philip M Potter; Patrick J Casey
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

4.  A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.

Authors:  Yuguo Li; Vipul R Sheth; Guanshu Liu; Mark D Pagel
Journal:  Contrast Media Mol Imaging       Date:  2010-11-30       Impact factor: 3.161

5.  No Dataset Left Behind: Mechanistic Insights into Thyroid Receptor Signaling Through Transcriptomic Consensome Meta-Analysis.

Authors:  Scott A Ochsner; Neil J McKenna
Journal:  Thyroid       Date:  2020-01-29       Impact factor: 6.568

6.  Functional Study of Carboxylesterase 1 Protein Isoforms.

Authors:  Xinwen Wang; Jian Shi; Hao-Jie Zhu
Journal:  Proteomics       Date:  2019-01-25       Impact factor: 3.984

7.  Catabolism of 4-hydroxy-2-trans-nonenal by THP1 monocytes/macrophages and inactivation of carboxylesterases by this lipid electrophile.

Authors:  Abdolsamad Borazjani; Mariola J Edelmann; Katelyn L Hardin; Katye L Herring; J Allen Crow; Matthew K Ross
Journal:  Chem Biol Interact       Date:  2011-08-22       Impact factor: 5.192

8.  Examination of the carboxylesterase phenotype in human liver.

Authors:  Matthew K Ross; Abdolsamad Borazjani; Ran Wang; J Allen Crow; Shuqi Xie
Journal:  Arch Biochem Biophys       Date:  2012-04-16       Impact factor: 4.013

Review 9.  The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Authors:  S Casey Laizure; Vanessa Herring; Zheyi Hu; Kevin Witbrodt; Robert B Parker
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

10.  Carboxylesterases: Dual roles in lipid and pesticide metabolism.

Authors:  Matthew K Ross; Timothy M Streit; Katye L Herring
Journal:  J Pestic Sci       Date:  2010       Impact factor: 1.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.